Melvyn Freeman, Michelle Funk, Soumitra Pathare et al.
1
Menschenkind, HVD, et al.
1
Mercedes M. Maicán V., Ángel Granado, Jesús Cedeño, et al.
1
Mesic, Anita
1
Mèdecines sans Frontières MSF
1
Médecins sans Frontières MSF
1
Michigan State University, USAID
1
Minh D Pham
1
Ministerio de Salud y Protección Social
1
Ministery of Public Health, Thailand
1
Ministère de la Santé et de l’Action Sociale et Ministère de la Justice
1
Ministère de la Santé Publique et de la Population (MSPP) Haiti
1
Ministère de la Santé Publique, Republique Démocratique du Congo
1
Ministério da Saúde Direcção Nacional de Saúde Pública Programa Nacional de Controlo da Tuberculose
1
Ministério da Saúde, Brasil
1
Ministry of health
1
Ministry of Health & Family Welfare Government of the Peoples Republic of Bangladesh
1
Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh
1
Ministry of Health and Family Welfare, Government of India
1
Ministry of Health and Sanitation Sierra Leone
1
Ministry of Health and Social Welfare, India
1
Ministry of Health and Social Welfare, Government of India
1
Ministry of Health and Social Welfare, Zimbabwe
1
Ministry of Health Ghana
1
Ministry of Health Jordan
1
Ministry of Health, Ethiopia
1
Ministry of Health, Kingdom of Cambodia
1
Ministry of Health, Liberia, World Health Organization (WHO), and Centers for Disease Control and Prevention (CDC)
1
Ministry of Health, Madagascar
1
Ministry of Health, Rwanda
1
Ministry of Health. The Goverment of the Kingdom of Swaziland
1
Ministry of Medical Services, Kenya
1
Ministry of Public Health & Sanitation
1
Misereor, Brot für die Welt, GPF
1
Montelongo, A.
1
MONWANOU Djohodo Inès
1
Morse S.
1
MSF Access Campaign
1
MSF Médecins sans Frontières
1
MSF South Africa and Lesotho
1
MSH, USAID
1
Murni I. K., T. Duke, S. Kinney et al.
1
Müller, Olaf
1
Mwangi, Annabel
1
Myanmar, Ministry of Health and Sports
1
N. B. Karkara
1
N. Chowdhary, S.Dimidji and V. Patel
1
N. Forda
1
N. González Méndez de Vigo, J. Karpenstein und F. Schmidt
1
N.Paul, T. Bärnighausen, P. Geldsetzer
1
NACO
1
Nana Twum Danso, Uta Lehmann, Jennifer Nyoni et al.
1
National Academy of Medical Sciences
1
National Agency for the Control of AIDS (NACA)
1
National AIDS
1
National AIDS Control Council
1
National AIDS Control Organisation (NACO)
1
National AIDS&STI Control Program Kenya
1
National Cancer Control Programme, India
1
National Centre for Disease Control (formerly National Institute of Communicable Diseases)
1
National Council on Disability Affairs (NCDA)
1
National COVID-19 Clinical Evidence Tasforce
1
National Department of Health South Africa
1
National Health Mission (NHM), Ministry of Health & Family Welfare, Government of India
1
National Institue of communicable Diseases, India
1
National Institute of Health
1
National Institute of Mental Health & Neurosciences, Bengaluru India
1
National Malaria Control Programme (NMCP) Communicable Disease Control Division Directorate General of Health Services Ministry of Health & Family Welfare Bangladesh
1
National Rural Health Mission
1
National Statistical Office Zomba, Malawi
1
NCDC
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Nepal Public Health Foundation
1
Net Hope
1
Neuropsychiatric hospital, Aro, Abeokuta, Nigeria
1
Nicole Ritz, Folke Brinkmann, Cornelia Feiterna-Sperling. et al.
1
Nkhoma, L. et all.
1
Norwegian Ministry of Foreign Affairs
1
Nwe Ni Myint et al.
1
O'Sullivan, B.
1
O. Ajose
1
O. Drouin
1
OEA (Más derechos para más gente)
1
OECD
1
Office for the Coordination of Humanitarian Affairs OCHA
1
Olans R. N. , R. D. Olans, A. DeMaria Jr
1
Olney, Jack J.
1
Open Journal of Epidemiology
1
OPSIC
1
Organisation for Economic Co-operation and Development (OECD)
1
Organisation for the Prohibition of Chemical Weapons (OPCW)
1
Organisation Mondiale de la Sante
1
Organización Mundial de la Salud
1
Organização Mundial da Saúde (Américas)
1
Organização Pan-Americana da Saúde
1
Oxfam Deutschland e.V.
1
Oxford
1
Öztürk, H.
1
O’Sullivan BG., Chater AB, Bingham A., et al.
1
P. Booth
1
P. De Castro
1
P. J. Dodd
1
PAHO/World Health Organization
1
Pan African Medical Journal
1
Pan American Health Organization (PAHO)
1
Pan American Health Organization PAHO, World Health Organization WHO
1
Papst Franziskus
1
Pathfinder International
1
Patrick Smith, T. Dalgleish and R. Meiser‐Stedman
1
Páez Silva, Gustavo Alejandro
1
Peace Corps
1
Peter Cooper, Robert Johnson, Haroon Saloojee et al.
1
Peter Stastny
1
Peyton, D.
1
Philippine Society for Microbiology and Infectious Diseases
1
Philippine Society for Microbiology and Infectious Diseases, Philippine College of Chest Physicians, Philippine Academy of Family Physicians
1
Phillipine Department of Health
1
Phillips, Tamsin K.
1
Phimemon, Rune N., Michael J. Mahande, and Habib O. Ramadhani
1
PMC
1
PMC (US National Library of Medicine National Institutes of Health)
1
Poe Poe Aung
1
Prince, M., and J. Jackson
1
Prof. AHM E. Hussain
1
Prof. Dr. P. Bendel
1
Programme National de lutte contre la Tuberculose (PNT) - Sénégal
1
Programme national de lutte contre la tuberculose - Sénégal
1
Public Health Foundation India
1
PubMed.gov
1
Queeramnesty Schweiz
1
R Wood, L-G. Bekker
1
R. Baggaley
1
R. Bucciardini
1
R. Coninx
1
R. Furth
1
R. Granich
1
R. Jahn
1
R. L’Herminez
1
R. Turner
1
R4V
1
Raftery A, Tudor C, True L, Navarro C
1
Rahman-Shepherd, A.
1
Rajan, S.
1
Ramanathan, K.
1
Rasmussen, D.J., Karsberg, S., Karstoft, K-I. & Elklit, A.
1
rbfhealth.org
1
ReAct Action on Antibiotic Resistance
1
refugio stuttgart e.v.
1
Regina Hiller
1
Regional Office for Africa
1
Regional refugee & resilience plan in response to the Syria crisis
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,... Switzerland, from 5 to 7 October 2009. This allowed the Consultation to benefit from the participation of the national coordinators and advisers of the BMGF-funded projects in the Philippines, South Africa (KwaZulu-Natal) and the United Republic of Tanzaniamore
EuroHealth ObserverEuropean Observatory on Health Systems and Policies Eurostation
(2020)
C2
The focus of the current quarterly edition of Eurohealth (from the European Observatory on Health Systems and Policies) is Antimicrobial Resistance (AMR) and contains the following articles:
• Strengthening implementation of AMR national action plans
• Fostering clinical developmen...t and commercialisation of novel antibiotics
• Tackling AMR in the community
• Quantifying the benefits of vaccines in combating AMRmore
Promoting health and preventing disease is a critical component of the effort required to achieve Universal Health Coverage (UHC). to date, efforts to achieve UHC have focused mostly on strengthening health systems and their capacities to provide curative care. However, experience from the COVID-19 ...pandemic has reaffirmed the need for resilient health systems, emphasizing primary health care, including preventive and promotive health and well-being.
Emerging from the eye of the storm as the global health lead agency during the pandemic, WHO is equipped with the required insights and actions for a holistic approach to “building back fairer and better” after COVID-19.
The Healthier Populations (UHP) Cluster in the African Region is designed to support Pillar 3 of WHO’s 13th Global Programme of Work (GPW13) which aims to make 1 billion people healthier by reducing health inequities, preventing diseases and injuries, addressing health determinants, and promoting partnerships for collaborative actions amongst all stakeholders.more
Today, patient harm due to unsafe care is a large and growing global public health challenge and is one of the
leading causes of death and disability worldwide. Most of this patient harm is avoidable. As countries strive to
achieve universal health coverage and the Sustainable Development Goals, t...he beneficial effects of improved
access to health services can be undermined by unsafe care. Patient safety incidents can cause death and
disability, and suffering for victims and their families. The financial and economic costs of safety lapses are high.
There is often reduced public confidence and trust in local health systems when such incidents are publicized.
Health workers involved in serious incidents involving death or serious harm to a patient can also suffer lasting
psychological harm and deep-seated feelings of guilt and self-criticism.more
Although the practice of communication is often called upon when intervening asn involgvingcommunties affected by NTD's, the disciplinary framewokr of healt communication research has been largely absent from NTD strategies. To illustrate how practices conceptualized and developed within the communi...cation field habe been applied in the context of NTD elimination, we conducted a scoping review focusing on two diseases currently targeted for elimination by the WHO: lymphatic filariasis and Chagas diseasemore
Neglected tropical diseases tend to cluster in the same poor populations, and to make progress with their control, they will have to be dealt with in an integrated manner. Peptide microarrays may be a solution to tese problems, where diagnosis for co-infection can be detected simultaneously using th...e one tool.more
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based, ...cost-effective interventions, the number of deaths per year is projected to reach approximately 416 000 globally in 2035. It was estimated in 2020 that 32% of incident cervical cancer cases and 34% of cervical cancer deaths in the world occurred in the 11 Member States of the WHO South-East Asia (SEA) Region. In 2020, 190 874 new cases and 116 015 deaths were estimated due to cervical cancer, which is the third commonest cancer in the Regionmore
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci..., which are located
in Sub-Saharan Africa, mainly in remote rural areas. The risk of contracting HAT is, therefore, determined by the possibility of contact of a human being with an infected tsetse fly. Epidemics of HAT were described at the beginning of the 20th century; intensive activities have been set up to confront the disease, and it was under control in the 1960s, with fewer than 5,000 cases reported in the whole continent.more
Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because of the impact of epilepsy on wages, health costs and social stigmatization of sufferers. ...Health systems are also burdened as treatments must be tailored to individual needs.more
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...placing Delta worldwide – was considered Omicron has a substantial growth advantage, higher secondary attack rates and a higher observed reproduction number than Delta.
There is now significant evidence that immune evasion contributes to the rapid spread of Omicron. Other factors may be a shorter
serial interval (by about 0.8 to 1.2 days compared to Delta) and potential increased intrinsic transmission fitness . There is
growing evidence that with Omicron, there is lower vaccine effectiveness (VE) against infection and symptomatic disease soon after vaccination compared to Delta. There is also evidence of accelerated waning of VE over time of the primary series against infection and symptomatic disease for the studied vaccines. Further studies are required to better understand the drivers of transmission and declining incidence in various settings. These factors include the intrinsic transmission fitness properties of the virus, degree of immune evasion, vaccination coverage and level of vaccine-derived and post-infection immunity, levels of social mixing and degree of application of public health and social measures (PHSM).more
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...ies (4). Vaccination has substantially reduced case numbers and hospitalizations in many countries,but limitations in global access to vaccines mean that many populations, including those in low- and middle-income countries, remain vulnerable. Even in vaccinated individuals, uncertainties remain about duration of protection and efficacy, and the degree of crossprotection with new variants.
There remains a need for more effective treatment and management for those affected by COVID-19. The pandemic – and the
explosion of both research and misinformation – has highlighted the need for trustworthy, accessible and regularly updated living
guidelines to place emerging findings into context and provide clear recommendations for clinical practicemore
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...nes.more
The Global vector control response 2017–2030 (GVCR) provides a new strategy to strengthen vector control worldwide through increased capacity, improved surveillance, better coordination and integrated action across sectors and diseases.
In May 2017, the World Health Assembly adopted resolutio...n WHA 70.16, which calls on Member States to develop or adapt national vector control strategies and operational plans to align with this strategy.more
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...c practices and tools associated with each use case.
- Analyze progress toward robust diagnostics for HAT across different biomarkers.
- Develop recommendations for steps to improve the availability, access, and adoption of HAT diagnostic tools.more
Every day in 2020, approximately 800 women died from preventable causes related to pregnancy and childbirth - meaning that a woman dies around every two minutes.
Sustainable Development Goal (SDG) target 3.1 is to reduce maternal mortality to less than 70 maternal deaths per 100 000 live births by ...2030.
The United Nations Maternal Mortality Estimation Inter-Agency Group (MMEIG) – comprising WHO, the United Nations Children’s Fund (UNICEF), the United Nations Population Fund (UNFPA), the World Bank Group and the United Nations Department of Economic and Social Affairs, Population Division (UNDESA/Population Division) has collaborated with external technical experts on a new round of estimates covering 2000 to 2020. The estimates represent the most up to date, internationally-comparable MMEIG estimates of maternal mortality, using refined input data and methods from previous rounds.
The report presents internationally comparable global, regional and country-level estimates and trends for maternal mortality between 2000 and 2020.more
This brochure presents a summary of the situation of health systems and services in the Americas as they progress toward the achievement of universal access to health and universal health coverage (universal health). The information provided presents an overview of the situation before the COVID-19 ...pandemic, how the pandemic has impacted health systems, and recommendations to address current and future challenges for building resilient health systems to advance toward universal health in the Americas.more
In May the Sixty-sixth World Health Assembly adopted resolution WHA66.12 (1) on 17 neglected tropical diseases (NTDs). Among other measures, the resolution urges Member States to:
• ensure country ownership of prevention, control, elimination and eradication programmes;
• expand and implemen...t interventions and advocate for predictable, long-term international financing for activities related to control and capacity strengthening;
• integrate control programmes into primary health-care services and existing programmes;
• ensure optimal programme management and implementation;
• achieve and maintain universal access to interventions and reach the targets of the roadmap.more
Human schistosomiasis, a parasitic and often chronic illness, is one of the major neglected tropical diseases worldwide. It is estimated that 240 million people suffer from schistosomiasis, with more than 200000 fatalities recorded each year. Schistosomiasis is caused by an infection of the blood fl...uke Schistosoma and is transmitted to humans through direct contact with infected water.more
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the
South of the United States. It is an important cause of early mortality and morbidity, and it is associated with poverty and stigma. A third of
the cases evolve into chronic... cardiomyopathy and gastrointestinal disease. The infection is transmitted vertically and by blood/organ
donation and can reactivate with immunosuppression. Case identification requires awareness and screening programmes targeting the
population at risk (women in reproductive age, donors, immunocompromised patients). Treatment with benznidazole or nifurtimox is most
effective in the acute phase and prevents progression to chronic phase when given to children. Treating women antenatally reduces but does
not eliminate vertical transmission. Treatment is poorly tolerated, contraindicated during pregnancy, and has little effect modifying the
disease in the chronic phase. Screening is easily performed with serology. Migration has brought the disease outside of the endemic
countries, where the transmission continues vertically and via blood and tissue/organ donations. There are more than 32 million migrants
from Latin America living in non-endemic countries. However, the infection is massively underdiagnosed in this setting due to the lack of
awareness by patients, health authorities and professionals. Blood and tissue donation screening policies have significantly reduced
transmission in endemic countries but are not universally established in the non-endemic setting. Antenatal screening is not commonly
done. Other challenges include difficulties accessing and retaining patients in the healthcare system and lack of specific funding for the
interventions. Any strategy must be accompanied by education and awareness campaigns directed to patients, professionals and policy
makers. The involvement of patients and their communities is central and key for success and must be sought early and actively. This review
proposes strategies to address challenges faced by non-endemic countriesmore
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...ata on the clinical presentation of T.b. rhodesiense HAT is available. From 2006-2009 we conducted the first clinical trial program (I MPAMEL III) in T.b. rhodesiense endemic areas of
Tanzania and Uganda in accordance with international standards (ICH-GCP). The primary and secondary outcome measures were safety and efficacy of an abridged melarsoprol schedule for treatment of second stage disease. Based on diagnostic findings and clinical examinations at baseline we describe the clinical presentation of T.b. rhodesiense HAT in second stage patients from two distinct geographical settings in East Africa.more